Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: First Quarter ended March 31, 2013
Filing Date: April 30, 2013
This filing serves as a cover document announcing the release of the Company's first-quarter 2013 results via an Investor News release (Exhibit 99.1). The filing explicitly states that the detailed financial data is contained within the attached exhibit and is not fully reproduced in the text of the Form 6-K itself.
Key Financial Metrics
The text of this Form 6-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references the use of the following non-GAAP measures in the attached Investor News to supplement GAAP results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: Defined as a non-GAAP measure to enhance understanding of financial performance.
Reconciliations between these non-GAAP measures and GAAP measures are located in the attached Exhibit 99.1 and the Cash Flow Statement.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached Investor News (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP measures are provided to enhance the user's understanding of current financial performance and future prospects. They emphasize that these measures provide consistency and comparability with prior periods.
Regulatory Note: The filing includes a standard disclaimer that the attached Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 6-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for the actual numerical values of Q1 2013 revenue, net income, and EBITDA.
- Verify the reconciliation of non-GAAP measures (EBITDA and Free Cash Flow) to GAAP measures as required by Regulation G.
- Check the Cash Flow Statement within the exhibit for detailed liquidity data.
- Confirm any year-over-year percentage changes in key metrics, as these are not present in the cover filing.